In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes

S. Narreddy, E. Manavathu, P. H. Chandrasekar, G. J. Alangaden, S. G. Revankar

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objectives: Zygomycosis is an uncommon but devastating disease with few therapeutic options. Calcineurin inhibitors and sirolimus (mTOR inhibitor), commonly used in transplant patients as immunosuppressives, have antifungal activity. They are known to demonstrate synergy with triazoles against certain fungi, though limited data exist about their activity against zygomycetes. Our aim was to study the in vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. Methods: Drug interactions were assessed with chequerboard dilution for posaconazole with calcineurin inhibitors and sirolimus according to the CLSI M38-A2 method for filamentous fungi. Twenty-eight clinical isolates were studied, including Rhizopus arrhizus, Rhizopus microsporus, Rhizomucor pusillus, Mucor sp., Cunninghamella bertholletiae, Myocladus corymbifera and Apophysomyces elegans. Combinations of posaconazole with tacrolimus, cyclosporin A or sirolimus were used. Experiments were performed in duplicate. Mean fractional inhibitory concentration indices were calculated. Results: Posaconazole with calcineurin inhibitors demonstrated consistent synergy against C. bertholletiae, M. corymbifera and A. elegans, whereas synergy or no interaction was primarily observed against R. arrhizus, R. microsporus, R. pusillus and Mucor. Antagonism was seen with the combination of posaconazole and sirolimus. Strain variability was noted among the same species. Conclusions: The clinical significance of these findings is unclear, but further studies are warranted given the potential for concomitant use of these agents in transplant patients treated for zygomycosis.

Original languageEnglish (US)
Article numberdkq020
Pages (from-to)701-703
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume65
Issue number4
DOIs
StatePublished - Feb 3 2010

Fingerprint

Sirolimus
Bertholletia
Zygomycosis
Mucor
Rhizopus
Fungi
Cunninghamella
Rhizomucor
Transplants
Triazoles
Tacrolimus
Immunosuppressive Agents
Drug Interactions
varespladib methyl
Cyclosporine
Calcineurin Inhibitors
In Vitro Techniques
posaconazole

Keywords

  • Azole antifungals
  • Fungal susceptibility
  • Mucormycosis

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Narreddy, S., Manavathu, E., Chandrasekar, P. H., Alangaden, G. J., & Revankar, S. G. (2010). In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. Journal of Antimicrobial Chemotherapy, 65(4), 701-703. [dkq020]. https://doi.org/10.1093/jac/dkq020

In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. / Narreddy, S.; Manavathu, E.; Chandrasekar, P. H.; Alangaden, G. J.; Revankar, S. G.

In: Journal of Antimicrobial Chemotherapy, Vol. 65, No. 4, dkq020, 03.02.2010, p. 701-703.

Research output: Contribution to journalArticle

Narreddy, S, Manavathu, E, Chandrasekar, PH, Alangaden, GJ & Revankar, SG 2010, 'In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes', Journal of Antimicrobial Chemotherapy, vol. 65, no. 4, dkq020, pp. 701-703. https://doi.org/10.1093/jac/dkq020
Narreddy, S. ; Manavathu, E. ; Chandrasekar, P. H. ; Alangaden, G. J. ; Revankar, S. G. / In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. In: Journal of Antimicrobial Chemotherapy. 2010 ; Vol. 65, No. 4. pp. 701-703.
@article{4d305ec761a44f10a58d0905360d2269,
title = "In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes",
abstract = "Objectives: Zygomycosis is an uncommon but devastating disease with few therapeutic options. Calcineurin inhibitors and sirolimus (mTOR inhibitor), commonly used in transplant patients as immunosuppressives, have antifungal activity. They are known to demonstrate synergy with triazoles against certain fungi, though limited data exist about their activity against zygomycetes. Our aim was to study the in vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. Methods: Drug interactions were assessed with chequerboard dilution for posaconazole with calcineurin inhibitors and sirolimus according to the CLSI M38-A2 method for filamentous fungi. Twenty-eight clinical isolates were studied, including Rhizopus arrhizus, Rhizopus microsporus, Rhizomucor pusillus, Mucor sp., Cunninghamella bertholletiae, Myocladus corymbifera and Apophysomyces elegans. Combinations of posaconazole with tacrolimus, cyclosporin A or sirolimus were used. Experiments were performed in duplicate. Mean fractional inhibitory concentration indices were calculated. Results: Posaconazole with calcineurin inhibitors demonstrated consistent synergy against C. bertholletiae, M. corymbifera and A. elegans, whereas synergy or no interaction was primarily observed against R. arrhizus, R. microsporus, R. pusillus and Mucor. Antagonism was seen with the combination of posaconazole and sirolimus. Strain variability was noted among the same species. Conclusions: The clinical significance of these findings is unclear, but further studies are warranted given the potential for concomitant use of these agents in transplant patients treated for zygomycosis.",
keywords = "Azole antifungals, Fungal susceptibility, Mucormycosis",
author = "S. Narreddy and E. Manavathu and Chandrasekar, {P. H.} and Alangaden, {G. J.} and Revankar, {S. G.}",
year = "2010",
month = "2",
day = "3",
doi = "10.1093/jac/dkq020",
language = "English (US)",
volume = "65",
pages = "701--703",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes

AU - Narreddy, S.

AU - Manavathu, E.

AU - Chandrasekar, P. H.

AU - Alangaden, G. J.

AU - Revankar, S. G.

PY - 2010/2/3

Y1 - 2010/2/3

N2 - Objectives: Zygomycosis is an uncommon but devastating disease with few therapeutic options. Calcineurin inhibitors and sirolimus (mTOR inhibitor), commonly used in transplant patients as immunosuppressives, have antifungal activity. They are known to demonstrate synergy with triazoles against certain fungi, though limited data exist about their activity against zygomycetes. Our aim was to study the in vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. Methods: Drug interactions were assessed with chequerboard dilution for posaconazole with calcineurin inhibitors and sirolimus according to the CLSI M38-A2 method for filamentous fungi. Twenty-eight clinical isolates were studied, including Rhizopus arrhizus, Rhizopus microsporus, Rhizomucor pusillus, Mucor sp., Cunninghamella bertholletiae, Myocladus corymbifera and Apophysomyces elegans. Combinations of posaconazole with tacrolimus, cyclosporin A or sirolimus were used. Experiments were performed in duplicate. Mean fractional inhibitory concentration indices were calculated. Results: Posaconazole with calcineurin inhibitors demonstrated consistent synergy against C. bertholletiae, M. corymbifera and A. elegans, whereas synergy or no interaction was primarily observed against R. arrhizus, R. microsporus, R. pusillus and Mucor. Antagonism was seen with the combination of posaconazole and sirolimus. Strain variability was noted among the same species. Conclusions: The clinical significance of these findings is unclear, but further studies are warranted given the potential for concomitant use of these agents in transplant patients treated for zygomycosis.

AB - Objectives: Zygomycosis is an uncommon but devastating disease with few therapeutic options. Calcineurin inhibitors and sirolimus (mTOR inhibitor), commonly used in transplant patients as immunosuppressives, have antifungal activity. They are known to demonstrate synergy with triazoles against certain fungi, though limited data exist about their activity against zygomycetes. Our aim was to study the in vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes. Methods: Drug interactions were assessed with chequerboard dilution for posaconazole with calcineurin inhibitors and sirolimus according to the CLSI M38-A2 method for filamentous fungi. Twenty-eight clinical isolates were studied, including Rhizopus arrhizus, Rhizopus microsporus, Rhizomucor pusillus, Mucor sp., Cunninghamella bertholletiae, Myocladus corymbifera and Apophysomyces elegans. Combinations of posaconazole with tacrolimus, cyclosporin A or sirolimus were used. Experiments were performed in duplicate. Mean fractional inhibitory concentration indices were calculated. Results: Posaconazole with calcineurin inhibitors demonstrated consistent synergy against C. bertholletiae, M. corymbifera and A. elegans, whereas synergy or no interaction was primarily observed against R. arrhizus, R. microsporus, R. pusillus and Mucor. Antagonism was seen with the combination of posaconazole and sirolimus. Strain variability was noted among the same species. Conclusions: The clinical significance of these findings is unclear, but further studies are warranted given the potential for concomitant use of these agents in transplant patients treated for zygomycosis.

KW - Azole antifungals

KW - Fungal susceptibility

KW - Mucormycosis

UR - http://www.scopus.com/inward/record.url?scp=77952572377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952572377&partnerID=8YFLogxK

U2 - 10.1093/jac/dkq020

DO - 10.1093/jac/dkq020

M3 - Article

C2 - 20130026

AN - SCOPUS:77952572377

VL - 65

SP - 701

EP - 703

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 4

M1 - dkq020

ER -